ArticleCureus2026
Tolosa-Hunt Syndrome With Highly Elevated Interleukin-6 Levels.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tolosa-Hunt syndrome is a rare disorder of idiopathic granulomatous orbital inflammation associated with ipsilateral orbital pain and cranial nerve palsy. The patient is a 42-year-old Hispanic female with Ecuadorian ancestry who presented in remission of episodes of horizontal diplopia, left eye proptosis, and 8/10 sharp left eye pain that occurred 10 years ago and four years ago. Both episodes resolved with about five weeks of oral methylprednisolone dosing prescribed at onset of symptoms. She is successfully maintained on oral methylprednisolone six-day dose pack about twice yearly for moderate orbital pain. At the time of the diplopia four years ago, Magnetic Resonance Imaging showed a left cavernous sinus mass, which resolved on subsequent imaging. Her interleukin 6 (IL-6) serum level done during remission and during clinical episodes was highly elevated at 90.5 pg/ml (normal <5 pg/ml) and 68.7 pg/mL, respectively. Lower level during clinical episode may be due to use of oral steroid medication. The cytokine elevation may provide clues regarding the pathophysiology of this unusual neurological disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.